Towards More Personalized Surgical Indications for Thoracic Aortic Dilatation: Are We There Yet?

[1]  T. Sundt,et al.  Bicuspid aortic disease and decision making under uncertainty - The limitations of clinical guidelines. , 2015, International journal of cardiology.

[2]  J. Bavaria,et al.  Modeling of predissection aortic size in acute type A dissection: More than 90% fail to meet the guidelines for elective ascending replacement. , 2014, The Journal of thoracic and cardiovascular surgery.

[3]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[4]  J. Leipsic,et al.  Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. , 2014, The Canadian journal of cardiology.

[5]  A. Stuenkel,et al.  The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD). , 2014, Molecular genetics and metabolism.

[6]  M. Mack,et al.  How does the ascending aorta geometry change when it dissects? , 2014, Journal of the American College of Cardiology.

[7]  H. Dietz,et al.  Loeys–Dietz syndrome: a primer for diagnosis and management , 2014, Genetics in Medicine.

[8]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[9]  W. Edwards,et al.  Incidence of aortic complications in patients with bicuspid aortic valves. , 2011, JAMA.

[10]  Souvik Sen,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Circulation.

[11]  Magdi H. Yacoub,et al.  Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.

[12]  M. Yacoub,et al.  A measured approach to managing the aortic root in patients with bicuspid aortic valve disease , 2009, Current cardiology reports.

[13]  S. Siu,et al.  Outcomes in adults with bicuspid aortic valves. , 2008, JAMA.

[14]  D. Milewicz,et al.  MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. , 2007, Human molecular genetics.

[15]  K. Eagle,et al.  Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD) , 2007, Circulation.

[16]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections (vol 39, pg 1488, 2007) , 2008 .

[17]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[18]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[19]  M. Borger,et al.  Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? , 2004, The Journal of thoracic and cardiovascular surgery.

[20]  A Evangelista,et al.  The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. , 2000, JAMA.

[21]  J. Elefteriades,et al.  Familial patterns of thoracic aortic aneurysms. , 1999, Archives of surgery.

[22]  J. Elefteriades,et al.  What is the appropriate size criterion for resection of thoracic aortic aneurysms? , 1997, The Journal of thoracic and cardiovascular surgery.

[23]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.